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Background: The translation machinery underlies a multitude of biological processes within the cell. The design
and implementation of the modern translation apparatus on even the simplest course of action is extremely
complex, and involves different RNA and protein factors. According to the “RNA world” idea, the critical link in the
translation machinery may be assigned to an adaptor tRNA molecule. Its exceptional functional and structural
characteristics are of primary importance in understanding the evolutionary relationships among all these
macromolecular components.
Presentation of the hypothesis: The 2′-3′ hydroxyls of the tRNA A76 constitute chemical groups of critical
functional importance, as they are implicated in almost all phases of protein biosynthesis. They contribute to:
a) each step of the tRNA aminoacylation reaction catalyzed by aminoacyl-tRNA synthetases (aaRSs); b) the
isomerase activity of EF-Tu, involving a mixture of the 2′(3′)- aminoacyl tRNA isomers as substrates, thereby
producing the required combination of amino acid and tRNA; and c) peptide bond formation at the peptidyl
transferase center (PTC) of the ribosome. We hypothesize that specific functions assigned to the 2′-3′ hydroxyls
during peptide bond formation co-evolved, together with two modes of attack on the aminoacyl-adenylate
carbonyl typical for two classes of aaRSs, and alongside the isomerase activity of EF-Tu. Protein components of the
translational apparatus are universally recognized as being of ancient origin, possibly replacing RNA-based enzymes
that may have existed before the last universal common ancestor (LUCA). We believe that a remnant of these
processes is still imprinted on the organization of modern-day translation.
Testing and implications of the hypothesis: Earlier publications indicate that it is possible to select ribozymes
capable of attaching the aa-AMP moiety to RNA molecules. The scenario described herein would gain general
acceptance, if a ribozyme able to activate the amino acid and transfer it onto the terminal ribose of the tRNA,
would be found in any life form, or generated in vitro. Interestingly, recent studies have demonstrated the
plausibility of using metals, likely abandoned under primordial conditions, as biomimetic catalysts of the
aminoacylation reaction.
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The design and implementation of the modern system
of genetic code translation, even at its simplest, is an ex-
tremely complex process. The heart of the biosynthetic
machinery is the ribosome, ribonucleoprotein providing
link amino acids together based on the information
encoded in mRNA. The ribosome governs the collective
effects of various RNA, protein factors and other essen-
tial components to good advantage. Almost all stages of
this intricate process are mediated by adaptor tRNAs,
which recognize a triplet of nucleotides on the mRNA
through a complementarity determining region called an
anticodon, and carry a covalently attached cognate
amino acid [1].
The attachment of amino acids to specific adaptor
tRNAs is mediated by a group of canonical enzymes
known as aaRSs, which catalyze a two-step aminoacylation
reaction. The selectivity in recognition of both the amino
acid to be activated and the cognate tRNA constitutes a
crucial step in the fidelity of polypeptide chain formation.
Aminoacylated tRNA is delivered to the ribosome in a
ternary complex of aminoacyl-tRNA• GTP•EF-Tu (where
GTP is guanosine triphosphate and EF-Tu is the elong-
ation factor), which plays a substantial role in the de-
coding process.
At its core the ribosome might be thought of as an
ancient molecular machine governed by RNA. The mod-
ern ribosome is a 2.5-MDa riboprotein assembly com-
posed of two unequal subunits that associate upon
initiation of the biosynthetic cycle. The mRNA is decoded
at the small subunit, whereas peptide bond formation
occurs on the large subunit, within the PTC, buried deep
inside a cavity and primarily built of ribosomal RNA [2-4].
Two critical issues still remain to be clarified regarding
the translation machinery: the control mechanisms under-
lying both peptide bond formation, and the translocation
of the tRNA molecules.
Over the years peptidyl transferase activity saga has
undergone dramatic changes [5,6]. Initial models were
based on a ribosomal protein-based mechanism [7]. The
discovery of RNA-facilitated activity made rRNA-
mediated catalysis on the ribosome fashionable. With
the availability of high-resolution crystallographic struc-
tures of ribosomal subunits isolated from various
sources, knowledge of the structural organization and
functioning of the organelle took a quantum leap for-
ward, and compellingly confirmed that peptidyl transfer-
ase is an RNA enzyme [2,8]. More recent findings
revealed that the true catalyst behind peptide bond for-
mation appears to be the aminoacylated tRNA molecule.
Furthermore, the remarkable substitution of the tRNA
terminal ribose 2′-OH group with deoxy (H) or fluoro
(F) 2′-H or 2′-F results in at least a 106-fold reduction
in the rate of peptide bond formation [9]. This indicatesthat the 2′-OH group is a critical component of the
reaction (Figure 1).
Based on data from the crystal structures, and biochem-
ical analysis of translational machinery components, we
put forward a hypothesis whereby the mechanism of pep-
tide bond formation on the ribosome co-evolved, in paral-
lel with the aminoacylation and editing activities of aaRSs.
Meanwhile, the elongation factor co-evolved with some
aaRSs, to securely transfer 3′-OH aminoacylated tRNAs
on the ribosome.
Presentation of the hypothesis
AaRSs and their role in translation
Prior to polypeptide chain synthesis, aaRSs provide the
ribosome with amino acid substrates in the form of
aminoacyl-tRNAs (aa-tRNAs). AaRSs constitute a large
family of enzymes partitioned into two distinct classes
varying greatly in their structural organization, and their
mode of interaction with tRNA [10]. Class I aaRSs
exhibit catalytic domains containing the classical
nucleotide-binding Rossmann fold, and amino acylation
reactions involve Trp, Tyr, Gln, Glu, Lys-1, Val, Ile, Leu,
Met, Arg and Cys substrate amino acids. Class II aaRSs
exhibit catalytic domains built around an antiparallel
β-sheet flanked by α-helices, and acylate their cognate
tRNA with Pro, Thr, Ser, Asp, Asn, Lys-2, His, Ala,
Gly, Phosphoserine, Pyrrolysine, and Phe substrate
amino acids. Along with amino acids delivering to the
ribosome, aaRSs maintain the high fidelity of genetic
code translation. They catalyze the attachment of
amino acids to the 3′- end of the tRNA in a two-step
aminoacylation reaction: a) first, the aaRS binds ATP and
the amino acid (aa), catalyzing formation of the intermedi-
ate aminoacyl-adenylate (aa-AMP); and b) secondly, the
amino acid is transferred to the cognate tRNA, cova-
lently binding to either the 2′OH or 3′OH of the
A76 terminal ribose. For class I aaRSs, the primary
site of aminoacylation is the 2′-OH group of ribose,
whereas for class II aaRSs, this site is the 3′-OH
group (with the exception of PheRS, which structur-
ally belongs to class II aaRSs, but aminoacylate the
2′-OH group) [11].
According to the well-studied mechanism of amino acid
activation, the geometry and charge of a pentacovalent
transition state should be stabilized by positively charged
amino acids and divalent cations (magnesium or possibly
manganese) [12]. A large body of evidence [2,3,13]
suggests that upon transition state formation, ATP
and amino acid substrates are optimally oriented for an
“in-line” displacement reaction to occur. Analogous to
the formation of peptidyl-tRNA on the ribosome, syn-
thesis of aminoacyl-tRNA does not requires direct in-
volvement of aaRS residues in the catalytic process
(Figure 2) [14].
Figure 1 Model of the peptidyl-transferase reaction. In transition state analogs, the only group found within hydrogen-bonding
distance is the 2′-OH of A76 of peptidyl-tRNA in the P site. PDB Code: 1VQN.
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history of the translational apparatus, and in the main-
tenance of fidelity in genetic code translation, enables
one to hypothesize that aaRSs were among the earliest
proteins to appear: at present, they exist in all living or-
ganisms [15-17]. Moreover, one may speculate that class
II aaRSs, as well as the amino acids associated with
them, predate those of class I [16]. Firstly, class II aaRSsFigure 2 The second step of the aminoacylation reaction catalyzed b
aspartyl-adenylate carboxyl group. The positive-charged and class II invarian
aspartyl-adenylate phosphate group. PDB Code: 1C0A.predominantly aminoacylate tRNA with simpler, smaller
amino acids (e.g., Gly, Pro, Ala, Asp, Thr and Ser), many
of which play crucial roles in the formation of protein
folds. Notably, these same amino acids were found to be
the most abundant in the classical Miller experiments,
which attempted to imitate conditions of primordial
environments. Our second argument follows from the
observation that biosynthetic pathways of class II-y AspRS. The terminal 3′-OH ribose is positioned for attack on the
t arginine contributes to the neutralization and stabilization of the
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ate stages, as compared to class I representatives; fur-
thermore, they are mostly synthesized from components
of glycolysis and the Krebs cycle pathways [16]. Further-
more, many class II amino acids e.g. Ala, Asp, Gly, Ser,
and Thr (all 3′-OH aminoacylated) serve as metabolic
precursors for all the other amino acids [16]. Thirdly,
two-(G and C) and three-letter-based codons (G, C and
A) are believed to be related to ancient codons [18].
Analysis of these codon triplets revealed that most often,
they associate with class II amino-acids and with their
partner aaRSs. Detailed investigations showed that nine
out of the 12 amino acids codified by these codons
belong to class II-type amino acids, aminoacylating the
3′-OH of cognate tRNA [16].
The elongation factor EF-Tu as a 2′OH-3′OH isomerase
During the elongation step of protein synthesis,
aminoacylated tRNA is delivered to the ribosomal PTC,
aided by the GTP-binding elongation factor EF-Tu. The
GTP-bound form of EF-Tu brings the new aa-tRNA to
the empty A-site of the ribosome, in order for decoding
to occur. This triggers GTP hydrolysis, and leads to the
release of GDP-bound EF-Tu from the ribosome. The
initial step of EF-Tu-GTP-aa-tRNA interaction with
the ribosome, known as the “encounter complex”, entails
codon-independent binding. The rate of binding is de-
termined by EF-Tu interactions with the ribosome: this
step proceeds much more slowly with aa-tRNA alone
[19]. The rate constant for complex formation at 20°C is
about 10-8 M-1 s-1 [18,20]; relatively high, as compared
to typical rate constants previously reported for other
macromolecular systems. This indicates that the macro-
molecular association of the ternary complex with the
ribosome is not entirely random. On the other hand,
the fact that proper binding of aminoacylated tRNA to
the ribosome may happen without EF-Tu involvement,
suggests that this primitive translation system is also
active, even in the absence of protein factors [21,22].
A secondary function of EF-Tu is worthy of mention,
and crucial in determining the finer details of the mod-
ern translational apparatus. EF-Tu also acts as an isom-
erase, utilizing a mixture of the 2′(3′)- aminoacyl tRNA
isomers as a substrate, and converting them to uniform
3′-complexes [11]. Both 2′- and 3′-aminoacyl isomers
of ‘deoxy’ RNAs can bind EF-Tu · GTP, albeit with 50-
fold lower efficiency as compared to the native 2′(3′)-
aminoacyl-tRNA [23,24]. The preference for the 3′-isomer
of aa-tRNAs, upon complex formation with EF-Tu,
was also demonstrated by NMR results published by
S. Yokoyama et al. [25], and supported more recently
by X-ray analysis of EF-Tu complexed with aa-tRNA
[26], and data from steady-state and transient kinetic
experiments [26,27]. Under standard physiologicalconditions, the transacylation rate from 2′-OH to 3′-OH
isomers is slower than the overall rate of polypeptide
chain elongation in the ribosome. Taken together, these
findings suggest that the appearance of aaRSs catalyzing
2′-OH aminoacylation should be accompanied by the
appearance of Ef-Tu stabilizing 3-OH aminoacylated
isomers.
The co-evolution of Ef-Tu and class I aaRSs
Structural and phylogenetic analyses suggest that class I
aaRSs evolved relatively late in evolution, from enzymes
involved in cofactor biosynthesis [22]. Class I aaRSs were
originally adapted to aminoacylate tRNA, for the most
part with the “large” biosynthetically complex amino
acids. Thus, it seems likely that class I aaRSs evolved in
an environment populated by a number of proteins,
coupled with the relatively efficient translation ma-
chinery. It has now become clear that the kinetic
mechanism of aminoacylation differs between the two
classes, and that they do not, as previously proposed,
“represent common orthogonal chemical solutions to
the aminoacylation of the tRNA” [28]. Many class I en-
zymes (e.g., CysRS, ValRS, IleRS, ArgRS, and GlnRS)
exhibit burst kinetics, suggesting that product release is
rate-limiting; whereas class II enzymes are rate-
limited at the amino acid activation stage [29]. More-
over, aminoacylation reactions performed in the presence
of EF-Tu demonstrate that the elongation factor select-
ively enhances the activity of class I aaRSs by promoting
enzyme turnover.
In essence, formation of the EF-Tu ternary complex
helps to activate the release of aa-tRNAs from class I
aaRSs, thereby speeding up the process of protein synthe-
sis. However, formation of the ternary complex aaRS−EF-
Tu−tRNA occurs in class I aaRSs only (Figure 3a). EF-Tu
fails to exhibit significant binding affinity to class II aaRSs,
as they basically attach amino acids to the A76 3′-OH,
thereby forming, in solution, more stable 3′-isomers,
already prepared for delivery to the ribosome. Moreover,
class II aaRSs approach the tRNA acceptor stem from the
same side of the major groove as EF-Tu. Thus, formation
of a stable assembly involving class II aaRSs, EF-Tu, and
aa-tRNA is hardly probable, in view of its sterical unfeas-
ibility (Figure 3b).
Transformation of the tRNA aminoacylated at the 2′-
OH of the terminal ribose to the 3′-OH variant, and
utilization of the EF-Tu in securing this state, underscores
the fundamental role played by tRNA aminoacylated
specifically on the 3′-OH. Involvement of the additional
enzyme converting 2′-OH to the 3′-OH aminoacylated
tRNA and, at a later stage, delivering the stabilized variant
to the PTC of the ribosome supporting the hypothesis that
class I aaRSs evolutionarily evolved only after the appear-
ance of EF-Tu.
Figure 3 Superposition of crystal structures for two class I and class II aaRSs complexed with tRNAs, on that of EF-Tu and tRNA.
(a) Overlay of class I CysRS and EF-Tu with their tRNAs (CysRS in green, PDB Code-1V0B; EF-Tu in red, PDB Code 1B23; tRNAs in orange). (b) Overlay
of class II SepRS (PDB Code: 2DU3) and EF-Tu complexed with their tRNAs (SepRS in blue; EF-TU in red; tRNAs in orange). In view of the fact
that the structural folds of tRNAs in all complexes are similar in appearance, the models were generated by superposition of the respective
tRNA molecules.
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Many methanogenic Archaea lack a gene encoding
canonical class cysteinyl-tRNA synthetase (CysRS), as
well as genes analogous to those involved in bacterial or
eukaryotic cysteine biosynthesis [30,31]. However, an
indirect pathway to the formation of Cys-tRNACys in
these organisms was recently revealed [30]. In the first
stage, the enzyme O-phosphoseryl-tRNA synthetase
(SepRS) ligates O-phosphoserine to tRNACys; subsequently,
O-phosphoseryl-tRNACys is converted to Cys-tRNACys
by Sep-tRNA, forming Cys-tRNA synthase (SepCysC).
Such reactions can therefore be classified as tRNA-
dependent amino acid biosynthesis. It is conceivable
that the tRNA-dependent pathway of amino acid bio-
synthesis represents a remnant of RNA-based metab-
olism [32]. The class II enzyme SepRS most likely
utilizes the 3′-OH isomer of tRNA as a substrate.
Ancient organisms that incorporated cysteine into
polypeptide chains took advantage of this pathway,
while in the modern world, the majority of organisms
utilize a standard pathway involving class I CysRS.
The close association between the tRNA-dependent
pathways of cysteine aminoacylation in ancient Archaea
and in modern organisms provides a good example of
3′-OH to 2′-OH directional transition during evolution.
First, both CysRS and SepRS recognize similar identity
elements on the tRNACys molecule [33]. Secondly, bac-
terial CysRS is able to aminoacylate both the 2′-OH and
3′-OH groups of tRNACys (reviewed in [11]). In vitro,
the reaction rate of 2′-OH aminoacylation is about
one order of magnitude faster than that of 3′-OH
acylation [29]. The EF-Tu ternary complex tightly
binds CysRS in the nano-molar range, and appears to
enhance the stabilization of 3′-OH as a preferred site
for aminoacylation reactions [29].A striking structural similarity is seen when the central
part of the M. maripaludis SepRS tetramer is
superimposed onto the (αβ)2 heterotetramer of T.
thermophilus PheRS: the r.m.s.d. between 525 corre-
sponding Cα atoms in the two assemblies is only 2.2 Å
[34-38]. Four catalytic domains of the tetrameric SepRS
are congruent to the catalytic and catalytic-like domains
of T. thermophilus PheRS pertaining to α- and β-subunits,
respectively (Figure 4). In both proteins, the core region
is formed by a four-helix bundle interface [39]. The
similarity of the two enzymes in their quaternary
organization is of particular interest, since the diver-
gence of the two families may predate the LUCA.
Notwithstanding the fact that both enzymes share a
common origin, and structurally belong to class II aaRSs,
PheRS, in contrast to SepRS, attaches an amino acid to a
2′-OH of terminal adenosine. None of the crystal struc-
tures of PheRS complexed with functional ligands or their
analogues revealed a conformation of the CCA end that
was appropriate for aminoacylation of the 3′-OH group.
This is due to the fact that A76 doesn’t penetrate deeply
enough into the active site to create the required distance
between the 3’-OH and the α-carbonyl carbon of the
PheAMP, suitable for nucleophilic attack (Figure 5).
Rather, it is dictated by a trajectory whereby PheRS
approaches tRNAPhe. Interestingly, mitochondrial PheRS
(mitPheRS), as well as cytoplasmic PheRS, utilize the
2′-OH of tRNAPhe as the initial aminoacylation site.
However, measurements of the kinetic parameters of
tRNAPhe-CC-3′dA for mitPheRS revealed that the
mitochondrial enzyme requires both hydroxyl groups
of the terminal adenosine for efficient aminoacylation
to occur [40].
There are solid grounds for believing that PheRS was
one of the last class II enzymes to evolve. First,
Figure 4 Superposition of the catalytic cores of class II SepRS and PheRS (PheRS colored in red, blue, and green. SepRS colored
in white).
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since LUCA, a clear tendency toward increased phenyl-
alanine content in proteins has been seen. Secondly, the
crystal structures of bacterial PheRSs, composed of 22
structural domains, have shown that it is the most com-
plex aaRS. Bacterial, archaeal and eukaryotic (cytoplas-
mic and mitochondrial) PheRSs share a common
catalytic fold, with some redesign of the active site resi-
dues. The subunit organization of the enzymes, however,Figure 5 Comparison of the second step of the reaction catalyzed by
PheRS, the 2′-OH ribose is most suitable for attack on the phenyl-adenylatediffers substantially: loss of certain structural domains,
including those involved in anticodon recognition, or
acquisition of new ones suggests the emergence of the
different binding modes with cognate tRNAs, whose
identity elements vary in bacteria and eukaryotes [41,42].
Taken together, these findings suggest that the stereo-
chemical aspects of phenylalanine-specific recognition,
and the mechanism of its subsequent activation,
appeared prior to the acquisition of aminoacylation byPheRS (red) and AspRS (white). In contrast to other class II aaRSs, in
carboxyl group.
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to evolve beyond the divergence of the primary king-
doms and translational apparatus.
The editing activity of aaRSs and Ef-Tu
A cornerstone in the evolution of the genetic code
entails the transition from early proteins that may have
been inherently statistical that is, one of several stereo-
chemically analogous amino acids might have been
brought to a given position within the polypeptide chain,
to protein with unique sequence and 3D-structure. This
transition was basically secured by aaRSs, which guaran-
teed a selection of proper amino acids bound to cognate
tRNAs. The difficulties in discriminating between certain
amino acids whose chemical structures bore a close
resemblance were finally resolved with the discovery of
editing activity that prevents misactivation of non-
cognate amino acids (pre-transfer editing) [43] or
misaminoacylation of tRNA (post-transfer editing) [44].
The existence of this additional activity appears to main-
tain the rate of misincorporation of non-cognate amino
acids in vivo, at the level of approximately one error out
of every 104–105 reactions.
It would seem that the proofreading activity of aaRSs
evolved early in the evolution of the translation appar-
atus, as ancient class II aaRSs such as AlaRS, ProRS,
ThRS and PheRS acquired editing domains possessing
different architectures. As dissociation of tRNAs from
enzymes is not a rate-limited state for class II aaRSs, it is
feasible that class II aminoacylated tRNA frequently
utilizes the mechanism of trans editing. Indeed, as has
been demonstrated for AlaRS, recognition of misacylated
Ser-tRNAAla by distinct structural domains in the course
of the editing reaction suggests the immediate dissoci-
ation of aminoacylated tRNAs from aaRSs and their sub-
sequent rebinding, using different structural modules
[45]. In a number of experiments, it was also shown that
PheRS utilizes cis- as well as trans-editing mechanisms
[46-48]. Moreover, in the presence of EF-Tu, PheRS effi-
ciently competes with the elongation factor to rebind the
mischarged Tyr-tRNAPhe, and then rapidly hydrolyzes it at
the editing site, utilizing the trans- pathway. According to
experimental evidence [46], aminoacylation of 2′-OH by
PheRS in the presence of EF-Tu is accompanied by
stabilization of the 3′-OH isomer. Thus, for PheRS, we
anticipate that misacylated tRNA approaches the editing
site in both cis- and trans-states, being aminoacylated on
the 2′-OH and 3′-OH isomers, respectively. Paradoxically,
the same editing site and mechanism of hydrolysis serve
for two stereochemically different complexes of substrate
amino acids bound at 2′-OH-tRNA (cis-editing) and at
3′-OH-tRNA (trans-editing).
The editing activities of IleRS, LeuRS and ValRS,
which together form subclass Ia aaRSs, are known to beperformed by the hydrolytic CP1 domain fused to a cata-
lytic core comprising a Rossmann-fold domain. Experi-
mental evidence for the existence of an editing site far
removed from the synthetic site was first reported for
IleRS [49]. IleRS, LeuRS and ValRS, whose structures are
closely related, also display variations in their hydrolytic
mechanisms. IleRS edits the 3′-OH acylated tRNA, and
therefore most likely requires EF-Tu for stabilization of
the 3′-OH isomer [50]; while LeuRS and ValRS, which
edit tRNAs specifically from 2′-OH acylated tRNA,
probably utilize the cis mechanism of editing [50,51].
It might be well to point out that IleRS and LeuRS also
utilize a distinctive tRNA-dependent pre-transfer editing
activity within their synthetic sites [50,51].
Testing and implication of the hypothesis
Systematic analyses of structural and kinetic data re-
vealed that the principal components of the translation
apparatus, such as aaRSs, and the PTC of the ribosome,
only assist in the proper positioning of the reactants,
and do not directly participate in catalytic reactions. It is
remarkable that, in both the synthetic active site of
aaRSs and in the PTC, the major role is allocated to sub-
strate tRNA molecules. We therefore propose that even
in the modern biosynthetic machinery, the tRNA mol-
ecule functions merely as a ribozyme. In fact, some semb-
lance of a common strategy may be revealed between
ribozymes catalyzing the phosphophoryl-transfer reaction,
and peptide bond formation catalyzed by tRNA. For
example, the 2′-OH in group II introns and the terminal
3′-OH in group I introns, are both directly involved in the
intron cleavage reaction (reviewed in [52]).
The two vicinal hydroxyl functional groups are known
to have been present in the A76 ribose before the
partitioning of aaRSs into two “orthogonal” chemical
solutions to the aminoacylation of the 3′ end of the
tRNA occurred. Although 3′-aminoacyl-adenosine and
3′-aminoacyl-tRNA are more favoured energetically as
compared to the corresponding 2′-isomers [53], aaRSs
demonstrate roughly comparable numbers of 2′- and 3′-
aminoacylation sites in the two aaRSs classes. Attach-
ment of amino acids to 2′-OH or 3′-OH isomers was
recently shown by means of biomimetic systems; a pref-
erence for 3′-OH aminoacylation was also observed
[54]. It seems that the prevalence of the ribose 3′-OH
bound polymer is a universal trait, inherited due to
chemical necessity. It is also implied in the retention of
2′- and 3′-specificity in aaRSs belonging to prokaryotes
and eukaryotes. In particular, it should be emphasized
that this principle holds true, even with the distinctions
in tRNA binding modes and topology of the aaRS active
sites observed among the three kingdoms. From this,
it immediately follows that aaRS side chains forming
interior of the synthetic and editing sites are closely
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the architecture and domain composition of aaRSs
throughout evolution evolved at least synchronously with
their ability to discriminate between 2′ and 3′ OH-groups
in aminoacylation reactions, or later on. The chemical ac-
tivity of only two 2′-3′ OH-groups at the 3′-terminal ad-
enosine of tRNA, coupled with evolutionary pressure for
new functions of aaRSs, EF-Tu and ribosomes, created a
great deal of mechanistic diversity and specificity, on the
way to formation of newly synthesized polypeptide chains.
Reviewer’s comments
Reviewer 1: Dr. Henri Grosjean (nominated by
Dr. P. Lopez-Garcia)
In this manuscript, the authors hypothesize that the
specific functions assigned to the 2′-3′ hydroxyls during
peptide bond formation on the ribosome has co-evolved
with the mechanism of tRNA aminoacylation and
editing activities by the 2 classes of aminoacyl-tRNA
synthetases (aaRSs), and with the isomerase activity of
EF-Tu employing a mixture of the 2′(3′)-aminoacyl-
tRNA isomers as substrates. Their main idea of the
paper is that the true catalysts of peptide bond forma-
tion on the ribosome are the aminoacylated tRNA mole-
cules, the aaRSs and the PTC of ribosome mainly
allowing the proper positioning of the aa-tRNAs with
the respective active sites. In other words, the tRNA
molecule merely functions as a ribozyme, an idea that
fits with the now generally admitted hypothesis that
ancient protein synthesis machinery was governed by
RNA. This paper is a logical prolongation of an earlier
work (J. Theor Biol-2004) more focused on the coevolu-
tion hypothesis between amino acid biogenesis, aaRSs
and the genetic code. These two papers complete each
other very well. The present manuscript is clearly writ-
ten, and while no experimental evidences are provided,
the hypothesis is convincing.
Minor remarks: Page 8 GCA ancient codon? This
should be developing a bit because the argument is not
obvious. Page 9 > > 20° should be 20°C of course. Page
15, cys-editing should be written cis-editing (this mis-
take occurs 3 times in the text).
Authors’ response: We accepted all the remarks of
Reviewer 1, and corrected the text accordingly. As to the
antiquity of the GCA codons, we added a few sentences at
the end of that discussion, to clarify our arguments.
Reviewer 2: Prof. Manuel Santos (nominated by
Prof. Yitzhak Pilpel)
In this hypothesis paper Mark Safro and Liron Klipcan
put forward the hypothesis that the functions of the 2′and 3′ hydroxyls of the conserved tRNA 3′-terminal
adenosine (A76) observed during peptide bond forma-
tion at the peptidyl transferase centre (PTC) of the ribo-
some co-evolved with the two modes of attack on the
aminoacyl-adenylate carbonyl typical of the two classes
of aaRSs and also with the isomerase activity of EF-Tu.
The authors recognize the fundamental roles of the 3′-
OH and 2′-OH groups in protein synthesis and develop
their arguments with several examples that highlight the
relevance of the 2′-OH and 3′-OH chemistry at the
amino acid activation, editing, transfer to the elongation
factor and PTC levels. This is an expected outcome of
the 2′-OH and 3′-OH multilayered chemistry, it would
be surprising if it worked in a different manner. The
value of this highly descriptive hypothesis paper that re-
views old concepts is that it highlights the overlooked
chemistry of the 2′-OH and 3′-OH, bringing it to
current debate. This is important and sufficient to rec-
ommend its publication. However, there are several
aspects of the paper that should be improved before
publication, namely:
1. The first part of the manuscript (including the
abstract) is poorly written and should be improved. There
are many grammatical errors along the manuscript.
2. On page-4, third paragraph, the authors state that
“the ribosome is a spectacular fossil artefact”. Looking at
the ribosome as a fossil artifact is simply wrong. This
should be changed to make to sentence clear.
3. The 3 subheadings dedicated to the aminoacylation
reaction, the aaRS classes and the early role of Class-II
aaRS in genetic code translation should be fused into a
single subheading and the text shortened. It is too de-
scriptive and repetitive.
4. Page-14, second paragraph. The sentence “….
transtion from statistically encoded proteins to error-
prone translation” should be clarified. It does not make
sense.
5. Page -14, third paragraph, additional references
should be included. This is a highly speculative para-
graph that could be improved.
Quality of written English: Needs some language cor-
rections before being published.
Authors’ response: As to the criticism of the sentences
on pages 4 and 14 we formulated them in more clear
form by modifying the text thus: a) the sentence on page
4 now reads, “The ribosome is an ancient molecular
machine governed by RNA”; b) the corrected sentence
on page 14 now reads, “A cornerstone in the evolution
of the genetic code entails the transition from early pro-
teins that may have been inherently statistical; that is,
one of several stereochemically analogous amino acids
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polypeptide chain, to protein with unique sequences and
3D-structures.” According to the referee’s request we
added references within the third paragraph on page 14
and 15.
The authors agreed with the referee’s suggestion to im-
prove the first part of the manuscript by combining
three subheadings of the manuscript dedicated to the
aminoacylation reaction, the aaRS classes, and the early
role of Class-II aaRS in genetic code translation, into a
single section. We fully rewrote this part of the manu-
script. While we agree with the reviewer that the introduc-
tion should contain a more comprehensive description of
the translational apparatus, we would note that the mod-
ern system of genetic code translation, even at its simplest,
is an extremely complex process, and includes a fair num-
ber of macromolecular components. A detailed descrip-
tion of even its major elements would increase the length
of the manuscript dramatically.
Reviewer 3: Dr. Koonin E.V.
This article discusses a problem that is both enor-
mously important and staggeringly hard, namely the
origin of the modern-type translation system. The au-
thors suggest propose several interesting ideas and make
remarkable inferences. To me, the most striking point is
that tRNAs effectively act as ribozymes in the modern
translation system, both in the aminoacylation and in
the peptidyltransferase reactions. Even if not entirely
new, this is a startling conclusion, and I find it regret-
table that the authors explicitly mention it only in pass-
ing, in the Concluding Remarks. The main point of the
article, however, is the hypothesis that modern-type
translation started with aminoacylation of 3′-OH of A76
in tRNAs that is facilitated by Class II aaRS. Subse-
quently, under this scenario, Class I aaRS that initially
aminoacylate at 2′-OH of A76, followed by isomeriza-
tion facilitated by EF-Tu, were added to the system. The
idea that 3′-OH aminoacylation is primordial certainly is
plausible, given that this is the final form in which
aminoacyl-tRNAs participate in peptide synthesis. Fur-
thermore, the association of Class II aaRS with chem-
ically simple and supposedly primordial amino acids is
compatible with the primacy of this class. However, the
evidence of this primacy from protein sequence and
structure comparison is weak at the very best. There is
just as good a reason to believe that Class II aaRS
evolved from coenzyme biosynthesis enzymes (biotin
synthetase, same superfamily in SCOP) as there is for
class I aaRS, it is just less well publicized. Furthermore,
the fact that the substrate-binding domain of class I
aaRS belongs to one of the most common, simple pro-
tein folds (the Rossmann fold) whereas Class II enzymesadopt a more rare and complex fold, might be used as
argument for the primacy of Class I. Moreover, the au-
thor repeatedly imply that the transition from statistical
peptide synthesis to modern type translation was
brought about by the recruitment and diversification of
the aaRS. This is extremely unlikely to be the case be-
cause both classes of the aaRSs seem to be rather late
arrivals in the evolution of the respective protein folds,
their emergence being antedated by extensive protein
evolution [1,2]. The same holds for EF-Tu which belongs
to a small branch within the huge GTPase superfamily
[3]. Thus, counterintuitive as that might seem, appar-
ently, there was a high-fidelity RNA-based translation
system, and one would think that the roots of the key
features of modern translation should be sought there.
In that regard, it is very strange that the authors do not
examine the properties of the small aminoacylating
ribozymes which are among the most remarkable mole-
cules that are relevant for the origin of translation. The
GUGGC-3′ ribozyme indeed aminoacylates at 3′-OH
[4] which is fully compatible with the primacy of this
reaction.
Thus, the hypothesis proposed by the authors in itself
is indeed plausible and deserves publication and discus-
sion. However, in the present manuscript, much of the
argument is missing, flawed, muddled or tangentially
relevant. In addition to the major issues outlined above, I
find the discussion of cysteine incorporation in Archaea
(which the authors consider to be ancestral without any
good reason) as well as the mechanism of PheRS to be
largely irrelevant and more confusing than enlightening.
1. Aravind L, Mazumder R, Vasudevan S, Koonin EV:
Trends in protein evolution inferred from sequence
and structure analysis. Curr Opin Struct Biol. 2002,
12:392-399.
2. Aravind L, Anantharaman V, Koonin EV: Mono-
phyly of class I aminoacyl tRNA synthetase, USPA,
ETFP, photolyase, and PP-ATPase nucleotide-binding
domains: implications for protein evolution in the
RNA. Proteins 2002, 48:1-14.
3. Leipe DD, Wolf YI, Koonin EV, Aravind L: Classifi-
cation and evolution of P-loop GTPases and related
ATPases. J Mol Biol 2002, 317(1):41-72.
4. Yarus M: The meaning of a minuscule ribozyme.
Philos Trans R Soc Lond B Biol Sci. 2011, 366:2902-2909.
Authors’ response:
a. Reviewer’s comment: “..the association of Class II
aaRS with chemically simple and supposedly primordial
amino acids is compatible with the primacy of this class.
However, the evidence of this primacy from protein se-
quence and structure comparison is weak at the very
best. There is just as good a reason to believe that Class
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(biotin synthetase, same superfamily in SCOP) as there
is for Class I aaRS, it is just less well publicized. Further-
more, the fact that the substrate-binding domain of
Class I aaRS belongs to one of the most common, simple
protein folds (the Rossmann fold) whereas Class II
enzymes adopt a more rare and complex fold, might be
used as argument for the primacy of Class I”.
Answer: Indeed, we agree that aaRSs associated with
class I and II aaRSs evolved at a time when some pro-
teins and canonical folds were already well-established.
These ancient proteins might be associated with coen-
zyme biosynthesis enzymes such as biotin synthetase, or
with biosynthesis of fatty acid derivatives, for example.
We previously showed that all structural domains of bio-
tin synthetase have structural homologs in multi-domain
β-subunit of PheRS. Remarkable similarity when all
structural domains of one multi-domain protein appear
to be constituents of the other multidomain protein sup-
ports a concept of a common ancestor for two different
enzymes [1,2].
In our discussion, we entertain the proposal that class
II aaRSs were the first to replace ribozyme-based
aminoacylation. Considerable evidence exists in favor of
this point: 1) the amino acids formed in the Miller ex-
periment are mostly class II-related; 2) the reconstructed
chronology of amino acids introduction into the genetic
code, as presented by E. Trifonov [3], strongly suggests
the association of early amino acids with class II; 3) the
so-called, more ancient “second genetic code”, located
in the stem-loop of the tRNA, is primarily recognized
by class II aaRSs; 4) our findings [4] suggest that
organization of amino acid biosynthetic pathways, and
clustering of aaRSs into different classes are intim-
ately related to one another. A plausible explanation
for such a relationship is dictated by early link be-
tween aaRSs and amino acid biosynthetic proteins.
The aaRSs’ catalytic cores are highly relevant to the
ancient metabolic reactions, namely to amino acid
and cofactors biosynthesis. In particular it has been
shown that class II aaRSs mostly associated with the
primordial amino acids, while class I aaRSs are usu-
ally related to amino acids that evolved at a later
stage [4]. The statement regarding the simplicity and
structural priority of the Rossmann fold, at least, is non-
trivial. For example it was hypothesized that aaRSs of two
classes were originally associated with one common tRNA
molecule [5,6]. Additionally, Carter and Duax in 2002
reported that complementary fragments of the specific
DNA region in Achlya klebsiana code for proteins
(not aaRSs) that have the same folds as class I and II
synthetases [7].1) Artymiuk PJ, Rice DW, Poirette AR, Willet P: A
tale of two synthetases. Nature Struct. Biol. 1994,
1:758-760.
2) Safro MG, Mosyak, L: Structural similarities in
the noncatalytic domains of phenylalanyl-tRNA and
biotin synthetases. Protein Science. 1995, 4:2429-2432.
3) Trifonov EN: Consensus temporal order of amino
acids and evolution of the triplet code. Gene. 2000,
261:139-51.
4) Klipcan L, Safro M: Amino acid biogenesis, evolu-
tion of the genetic code and aminoacyl tRNA synthe-
tases. J. Theor Biol. 2004, 238:389-396.
5) Rodin S, Rodin A, Ohno S: The presence of
codon-anticodon pairs in the acceptor stem of
tRNAs. Proc Natl Acad Sci U S A. 1996, 93:4537-42.
6) Ribas de Pouplana L, Schimmel P: Aminoacyl-
tRNA synthetases: potential markers of genetic code
development. Trends Biochem Sci., 2001, 26: 591-6.
7) Carter CW, Duax WL: Did tRNA synthetase clas-
ses arise on opposite strands of the same gene? Mol
Cell. 2002, 10:705–708.
b. Reviewer’s comment: “…I find the discussion of
cysteine incorporation in Archaea (which the authors
consider to be ancestral without any good reason) as
well as the mechanism of PheRS to be largely irrelevant
and more confusing than enlightening”.
Answer: Genome-wide analysis revealed that cysteine
content was dramatically increased (a so- called “gainer”
amino acid) only after the existence of LUCA, suggesting
late incorporation of cysteine into the genetic code [8,9].
Indeed, in organisms using the standard CysRS-tRNACys
pathway of aminoacylation, this probably is the case.
However, our concept is that high cysteine content in
methanogenic Archaea (considered being very ancient)
and the way it forms Cys-tRNACys (via a tRNA-dependent
pathway of cysteine biosynthesis, using L-phosphoserine
as a precursor, and the class II aaRS SepRS [10]), suggests
that cysteine was abundant in some ancient organisms.
We used this example as an indication of the antiquity of
tRNA-dependent pathways in such organisms. This point
of view was supported very recently by results published
by Zhang et. al. [11]: “These results indicate that tRNA-
dependent Cys biosynthesis appeared 500 million years
earlier (~3.5 Ga) than the tRNA-independent counterparts
(~3.0 Ga), supporting a previous opinion that tRNA-
dependent Cys biosynthesis had a very ancient origin
(Klipcan et al., 2008)”.
8) Jordan IK, Kondrashov FA, Adzhubei IA, Wolf YI,
Koonin EV, Kondrashov AS, Sunyaev S. A universal
trend of amino acid gain and loss in protein evolu-
tion. Nature. 2005, 433:633-8.
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eine, tyrosine, and phenylalanine residues since the last
universal ancestor.Mol Cell Proteomics. 2002, 1:125-31.
10) Sauerwald A, Zhu W, Major TA, Roy H, Palioura
S, Jahn D., Whitman WB, Yates JR 3rd, Ibba M, and Soll
D. RNA-dependent cysteine biosynthesis in archaea.
Science. 2005. 307:1969-1972.
11) Zhang H-Y, Qin T, Jiang Y-Y, Caetano-Anollés G.
Structural phylogenomics uncovers the early and con-
current origins of cysteine biosynthesis and iron-sulfur
proteins. J. Biom. Str. Dynamics, 2012; 30:542–545.
c) Reviewer’s comment: “…This is extremely unlikely
to be the case because both classes of the aaRS seem to
be rather late arrivals in the evolution of the respective
protein folds, their emergence being antedated by exten-
sive protein evolution [12,13]. The same holds for EF-Tu
which belongs to a small branch within the huge
GTPase superfamily [14].
Answer: We completely agree with the reviewer’s re-
mark that the RNA based translation system was already
well-established; thus, could be active without EF-Tu
[15,16] and based on aaRSs ribozymes.
12) Aravind L, Mazumder R, Vasudevan S, Koonin EV:
Trends in protein evolution inferred from sequence
and structure analysis. Curr Opin Struct Biol. 2002,
12:392-399.
13) Aravind L, Anantharaman V, Koonin EV: Mono-
phyly of class I aminoacyl tRNA synthetase, USPA,
ETFP, photolyase, and PP-ATPase nucleotide-binding
domains: implications for protein evolution in the
RNA. Proteins. 2002, 48:1-14.
14) Leipe DD, Wolf YI, Koonin EV, Aravind L: Classi-
fication and evolution of P-loop GTPases and related
ATPases. J Mol Biol. 2002, 317:41-72.
15) Gavrilova LP and Spirin AS: Stimulation of
"non-enzymic" translocation in ribosomes by p-
chloromercuribenzoate. FEBS Lett. 1971, 17:324-326.
16) Gavrilova LP, Kostiashkina OE, Koteliansky VE,
Rutkevich NM and Spirin AS: Factor-free (“Non-
enzymic”) and factor-dependent systems of transla-
tion of polyuridylic acid by Escherichia coli ribosomes.
J Mol Biol. 1976. 101:537-552.
This referee made remarks regarding the grammatical
imprecision, misspellings, and quality of the written
English. We accepted all his suggestions, and made cor-
rections accordingly. The manuscript was extensively
edited by a scientific editor.
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